“It might have benefit but is it worth it?" - Health Economic perspectives on Genomic Medicine.
A limited health care budget coupled with increasing demands raises questions concerning whether a health care system should fund developments in genomic medicine over competing priorities and services, such as public health interventions to reduce inequalities in healthcare, health and social care infrastructure, or introduction of new and often expensive therapies.
Health economics, a discipline concerned with the allocation of precious health care resources, can help inform this debate and provide policy advice. The "Genomic Medicine - Health Economics" satellite workshop will bring together health economists addressing such issues, to present their work on the health economics of genomic medicine. Presentations and discussions will be informative for geneticists, policy makers, clinicians and health economists.
Professor Mandy Ryan, Health Economics Research Unit, University of Aberdeen
Professor Olivia Wu, Health Economics and Health Technology Assessment (HEHTA), University of Glasgow
Professor Stephen Palmer, Centre for Health Economics, University of York
Fiona Murphy, Director, National Services Division, NHS Scotland
Professor Sarah Wordsworth, University of Oxford
Professor Deborah Marshall, University of Calgary
Local Organisers: Dr Mandy Ryan, University of Aberdeen, Dr Peter Hall, University of Edinburgh, Professor Tim Aitman, University of Edinburgh
Institute of Genetics and Molecular Medicine, Crewe Road South, Edinburgh, July 1, 2020
9.00am - 9.30am – Registration and coffee
Morning Session: Chaired by Professor Mandy Ryan, Health Economics Research Unit, University of Aberdeen
09.30am - 09.45am Welcome and overview of Health Economics (Professor Mandy Ryan)
09.45am – 10.15am Professor Olivia Wu, Health Economics and Health Technology Assessment (HEHTA), University of Glasgow will speak on HEHTA’s Precision Medicine research
10.15am - 10.45am Professor Stephen Palmer, Centre for Health Economics, University of York, will present research evaluating tumour agnostic/genomics directed therapies for metastatic cancer.
10.45am-11.15am Coffee break and networking
11.15am-11.45am Professor Mandy Ryan, Health Economics Research Unit (HERU), University of Aberdeen, will present on HERU’s research on evaluating the provision of WGS for diagnosis of rare disorders in NHS Scotland.
11.45am - 12.15pm Fiona Murphy, Director, National Services Division, NHS Scotland – Reflections on the value of health economics in the policy area.
Afternoon Session: Chaired by Dr Peter Hall, Health Economics Lead, University of Edinburgh Clinical Trials Unit
1.15pm -2.15pm Professor Sarah Wordsworth (University of Oxford) and Professor Deborah Marshall (University of Calgary) will reflect on their extensive health economics research informing the delivery of genomics medicine in England and Calgary respectively.
2.15pm – 2.45pm Closing thoughts: Professor Tim Aitman, Centre for Genomic and Experimental Medicine, University of Edinburgh and Professor Zosia Miedzybrodzka, Professor of Medical Genetics, University of Aberdeen.
2.45pm – 3.30pm Coffee and networking